Glucocorticoid receptor (GR) function may have aetiopathogenic significance in chronic fatigue syndrome (CFS), via its essential role in mediating inflammatory responses as well as in hypothalamic-pituitary-adrenal axis regulation. Here, NR3C1 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.